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ABSTRACT Single wavelength ﬂuorescence cross-correlation spectroscopy (SW-FCCS), introduced to study biomolecular
interactions, has recently been reported to monitor enzyme activity by using a newly developed ﬂuorescent protein variant
together with cyan ﬂuorescent protein. Here, for the ﬁrst time to our knowledge, SW-FCCS is applied to detect interactions
between membrane receptors in vivo by using the widely used enhanced green ﬂuorescent protein and monomeric red
ﬂuorescent protein. The biological system studied here is the epidermal growth factor/ErbB receptor family, which plays pivotal
roles in the development of organisms ranging from worms to humans. It is widely thought that a ligand binds to the monomeric
form of the receptor and induces its dimeric form for activation. By using SW-FCCS and Fo¨rster resonance energy transfer, we
show that the epidermal growth factor receptor and ErbB2 have preformed homo- and heterodimeric structures on the cell
surface and quantitation of dimer fractions is performed by SW-FCCS. These receptors are major targets of anti-cancer drug
development, and the receptors’ homo- and heterodimeric structures are relevant for such developments.
INTRODUCTION
Fluorescence cross-correlation spectroscopy (FCCS) is a
versatile technique for the quantitation of protein-protein
interactions in live cells (1). It is derived from ﬂuorescence
correlation spectroscopy (2) and is a technique to measure
molecular interactions with single molecule sensitivity, inde-
pendent of the size and mass of molecules under investiga-
tion. Its ﬁrst application to molecular interactions was shown
by Schwille et al. (3), and theories for ligand-receptor inter-
actions have previously been described (4,5). However, the
ﬁrst FCCS experiments used either two distinct lasers for
excitation (3) or two-photon excitation by a pulsed laser (6).
Application of FCCS to in vivo measurements has been
reviewed recently (7) and the use of ﬂuorescent proteins
(FPs) for FCCS has been demonstrated (5,8,9). However, the
use of two lasers or of one pulsed laser makes the setup either
difﬁcult to align or expensive (6,10,11). SW-FCCS has been
shown to work using a combination of ﬂuorescent and scat-
tered light (12) and has recently been applied to the analysis
of biomolecular interactions using only ﬂuorescence labels
(13–15). For the ﬁrst time we performed single wavelength
ﬂuorescence cross-correlation spectroscopy (SW-FCCS) on
FP-fusion receptors on the surface of single live cells to
quantitatively measure the receptor dimer fraction, using the
most widely used green ﬂuorescent protein (GFP) and mono-
meric red ﬂuorescent protein (mRFP) (16). Due to the long
tail of the excitation spectrum it is possible to excite both
ﬂuorophores with similar efﬁciencies at a wavelength of
514 nm. In addition to the use of recently developed FP mu-
tants with a large Stokes shift (8), this method offers the ad-
vantage of more stable ﬂuorophores and a longer excitation
wavelength, limiting cell damage and autoﬂuorescence.
Fo¨rster resonance energy transfer (FRET) is also often
considered an excellent method to monitor the interaction of
proteins within a microenvironment of 10 nm distance in
single cells in the native form (17), and has the potential to
address a large number of highly signiﬁcant structural infor-
mation within the cell without loosing the information on
small changes (18). It is based on the nonradiative energy
transfer between a donor and acceptor ﬂuorophore pair in
which the emission spectrum of the donor overlaps with the
excitation spectrum of the acceptor (19,20).
Epidermal growth factor receptor (EGFR) signaling is in-
volved in diverse physiological processes such as cell
proliferation and apoptosis. Upregulation of the EGFR/ErbB
family tyrosine kinase activity is frequently implicated in a
variety of human cancers (21). Ligand-induced dimerization
is proposed as a molecular mechanism underlying the ac-
tivation of all the growth factor receptor tyrosine kinases
including EGFR and ErbB2, also called HER2 or Neu (22,23).
Before ligand binding, however, it remains controversial
whether the receptor has a monomeric or dimeric structure
(24–28). Chemical cross-linking and coimmunoprecipitation
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have most commonly been used to detect dimers of the cell-
surface receptors. Unfortunately, all the chemical cross-linkers
are too unstable in aqueous buffer to quantitatively trap the
dimer (24,29), particularly at physiological expression levels
(,105 molecules per cell (30)). Meanwhile, coimmunopre-
cipitation cannot directly address whether the receptor has a
dimeric structure, although it can detect the receptor’s com-
plex in which they may not directly interact with each other
as a dimer. Because the dimeric structure might also be
unstable against detergent solubilization (24), the structural
analysis should be conducted in vivo on the surface of live
cells. In this study, therefore, we tried to detect cross corre-
lation and FRET due to homo- and heterodimeric structures
to examine the receptor’s ternary structure on the live cell
surface.
Thus by the novel combination of two methods, SW-
FCCS and FRET, we could demonstrate the preformed EGF/
ErbB2 receptors homo- and heterodimers in the native form
in single live cells. Most of the studies on the ErbB family
receptors by ﬂuorescence techniques that have been reported
were done through either ligand labeling or antibody con-
jugation, and measurements were carried out on cell lines
overexpressing the receptors (27,31,32). Here we mainly fo-
cused on cells that express physiological levels of the recep-
tors in the absence of ligand stimulation. Although Clayton
et al. reported the preformed homodimeric structure of EGFR
before activation (30), we further investigated the hetero-
dimeric structure between EGFR and ErbB2.
MATERIALS AND METHODS
Construction of plasmids encoding chimeras
between EGFR or ErbB2 and FPs
pNUT/EGFR plasmid DNA (24) was digested with KpnI, and the result-
ing fragment ends were repaired by treatment with T4 DNA polymerase. A
3.5-kb KpnI-BglII fragment encoding the N-terminal peptide of EGFR was
excised out from the fragment by digesting with BglII. A 0.8-kb fragment
encoding the C-terminus of EGFR was ampliﬁed by polymerase chain
reaction (PCR) with the following oligonucleotide primers encoding BglII
and AgeI sites (underlined), respectively: 59-CCAGCGAGATCTCCTC-
CATCC and 59-CCTCCGTACCGGTGCTCCAATAAATTCACTGC. The
latter primer also encodes a proline residue at the stop codon indicated in
italic. The resulting PCR fragment was digested with BglII and AgeI, and
cloned with the 3.5-kb KpnI-BglII fragment in tandem into pEGFP-N1,
pECFP-N1, and pEYFP-N1 (Clontech, Palo Alto, CA) digested with AfeI
and AgeI to make plasmid constructs encoding EGFR-GFP, EGFR-CFP, and
EGFR-YFP chimeras, respectively. A plasmid encoding an EGFR-mRFP
fusion protein was constructed by replacing the GFP gene of EGFR-GFP
with a PCR product ampliﬁed from pRSETB/mRFP, kindly provided by
Roger Tsien, University of California at San Diego, using the following
primers with an AgeI or NotI site (underlined), respectively: 59-GATC-
CACCGGTCGCCACCATGGCCTCCTCCGAGGACGTC, or 59-TTTTC-
CTTTTGCGGCCGCTTAGGCGCCGGTGGAGTG.
As negative controls, we also made plasmids encoding FPs fused to the
plasma membrane target (PMT) sequence at the FP’s N-terminus. The YFP
gene was ampliﬁed from pEYFP-N1 by PCR using a pair of primers,
59-AGCAAGCGGCGGAAGGCCGACAAGGAGAGCATGGTGAGCAAG-
GGC (PMS1) and 59-TTTTCCTTTTGCGGCCGCTTACTTGTACAGC-
TCGTC (PMS5). PMS1 encodes part of the PMT sequence (in italic) of the
X-linked retinitis pigmentosa protein RP2 (33), and PMS5 encodes a NotI
site (underlined). The resulting PCR product was then used as a template for
the second round of PCR with primers, 59-GATCCACCGGTATGGGCTG-
CTTCTTCAGCAAGCGGCGGAAG (PMS2), which encodes an AgeI site
(underlined) and the remaining sequence of PMT (in italic), and PMS5. To
construct a plasmid encoding a chimera, PMT-YFP, the resulting PCR
product was then doubly digested with AgeI and NotI, and was cloned into
pECFP-N1 fromwhich the FP gene was removed by digesting with AgeI and
NotI. Similarly, plasmids encoding PMT-CFP, PMT-GFP, and PMT-mRFP
were also made. Another negative control we used for SW-FCCS is the
cytosolic GFP/mRFP pair, in which the mRFP construct was simply am-
pliﬁed from pRSETB/mRFP vector and inserted into pEGFP-N1 vector
(Clontech) by replacing the EGFP sequence through AgeI and NotI sites.
A plasmid encoding a positive control, PMT-CFP-YFP, for the FRET
experiment was constructed in the following manner: the CFP gene was
ampliﬁed from pECFP-N1 using PMS1 and PMS3 (59-GCTCACCATGC-
CGCTCCCGGACCCCTTGTACAGCTCGTC) as primers, and the result-
ing PCR product was then used for the second round of PCR using PMS2
and PMS3 as primers. The YFP gene was also ampliﬁed by using a pair of
primers, 5-GGGTCCGGGAGCGGCATGGTGAGCAAGGGC (PMS4) and
59-GATCTAGAGGTCGCGGCCGCT (PMC1). The PMS4 encodes a ﬁve-
amino acid residue linker (underlined), and PMC1 encodes NotI (under-
lined). These ampliﬁed CFP and YFP gene products were then used for
overlap extension PCR (34) using primers, PMS2 and PMC1, to yield a full-
length PMT-CFP-YFP chimera. The resulting PCR product was digested
with AgeI and NotI, and then cloned into pEGFP-N1 from which the GFP
gene was removed by digestion with the two enzymes.
To construct plasmids encoding ErbB2-GFP, ErbB2-CFP, and ErbB2-
YFP, a 0.8-kb 39-terminal fragment of the ErbB2 gene was ampliﬁed from
pcDNA/ErbB2 (provided by Haihe Wang, Institute of Molecular and Cell
Biology, Singapore), in which the full-length human ErbB2 cDNA was
cloned between NheI and NotI sites of pcDNA 3.1/Zeo plasmid vector
(Invitrogen, Carlsbad, CA), by PCR using a pair of primers, 59-CTC-
CCGCATGGCCAGGGAC (primer A; this sequence resides upstream of a
unique AfeI site of the ErbB2 cDNA) and 59-CACCATCCCTCCACTCC-
CACTCCCTCCCACTGGCACGTCCAGACCCAGGTAC (primer B). The
primer B encodes a seven amino-acid residue linker that replaces the stop
codon. The GFP gene was also similarly ampliﬁed from pEGFP-N1 using
a pair of primers, 59-GCCAGTGGGAGGGAGTGGGAGTGGAGGGAT-
GGTGAGCAAGGGCGAGGAGCTG (primer C) and 59-GTCGCGG-
CCGCTTTACTTGTACAGCTCGTCC (primer D), which encodes NotI
(underlined). On the primers B and C, a seven amino-acid residue linker was
also underlined. The two PCR products were mixed for overlap extension
PCR with primers A and D, and the resulting product was digested with AfeI
and NotI. The fragment was cloned into pcDNA/ErbB2 digested with the
two enzymes, resulting in pcDNA/ErbB2-GFP. A plasmid encoding ErbB2-
mRFP was similarly constructed from a PCR product ampliﬁed from
pRSETB/mRFP using primers, 59-GCCAGTGGGAGGGAGTGGGAGTG-
GAGGGATGGCCTCCTCCGAGGACGTCATC and 59-GTCGCGGCCG-
CTTAGGCGCCGGTGGAGTGGCG.
To make the amino-terminal fusion construct of EGFR with FP, an XhoI
restriction site was created just after the signal peptide cleavage site of EGFR
by site-directed mutagenesis using a QuickChange XL kit (Stratagene,
La Jolla, CA), pNUT/EGFR as a template, and the following mutagenic
primers: 59-CCGGCGAGTCGGGCTCTCGAGGAAAAGAAAGTTTGC
and 59-TTGGCAAACTTTCTTTTCCTCGAGAGCCCGACT, in which
mutation sites are underlined. To construct an expression plasmid encoding
mRFP-EGFR, the mRFP gene was ampliﬁed by PCR from pRSETB/mRFP
with the following primers: 59-GCGCGCCTCGAGATGGCCTCCTCC-
GAGGACGTC and 59-GCGCGCCTCGAGACTCCCACTCCCTCCGGA-
TCCGGCGCCGGTGGAGTGGCG, in which XhoI sites are indicated by
underlines. The resulting PCR product was digested with XhoI and cloned
into the XhoI site of the EGFR gene of pNUT/EGFR(XhoI) to make pNUT/
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mRFP-EGFR(XhoI) encoding mRFP-EGFR, in which mRFP was fused to
the amino-terminus of EGFR. To create a plasmid encoding mRFP-EGFR-
GFP, the pNUT/mRFP-EGFR plasmid was digested with SmaI and AgeI,
and a 6.8-kb fragment lacking the carboxyl-terminus of EGFR was puriﬁed
after blunting the AgeI end with T4 DNA polymerase. A 3.6-kb SmaI-NotI
fragment of pEGFP-N1/EGFR-GFP was also puriﬁed after blunting the NotI
end, and cloned into the 6.8-kb fragment of pNUT/mRFP-EGFR to make
pNUT/mRFP-EGFR-GFP. In the similar way, plasmids encoding CFP-
EGFR-YFP or YFP-EGFR-CFP were also constructed from CFP and YFP
fragments ampliﬁed using a pair of primers; 59-GCGCGCCTCGAGATGG-
TGAGCAAGGGC and 59-GCGCGCCTCGAGACTCCCACTCCCTCCG-
GATCCCTTGTACAGCTCGTC.
All the constructs described above were conﬁrmed by DNA sequencing.
A schematic drawing of the constructs is shown in Fig. 1 A.
Cell culture and expression of receptor chimera
with FP
As introduced above, EGFR and ErbB2 cDNAs were modiﬁed so that the
clones can produce the receptor proteins fused with FPs at its carboxyl/
amino-terminus through a linker sequence. CHO-K1 cells purchased from
ATCC (Manassas, VA) were cultivated in Ham’s F12 medium (with
Kaighn’s modiﬁcation) supplemented with 2 mM L-glutamine, 1.5 g/L
sodium bicarbonate, 50 U/ml penicillin G, 50 mg/ml streptomycin, and
10% fetal bovine serum (FBS) at 37C in 5% (v/v) CO2 humidiﬁed
atmosphere. For the coexpression of two different fusion constructs, the
ratio of the amounts of the two plasmids was kept at 1:1 (2 mg EGFR-GFP/
2 mg EGFR-mRFP, for example) for transfection. For the triple expression
of FP-fusion plasmids and one wild-type (wt) receptor plasmid (pNUT/
EGFR), the ratio among the three plasmids was 1:1:0.5 and 1:1:1, respec-
tively. Two methods were mainly used to introduce plasmids DNA into
CHO cells, electroporation (Bio-Rad, Hercules, CA) and Fugene 6 trans-
fection kit (Roche Diagnostics, Singapore), and no difference in dimeriza-
tion of the receptors was observed between the two transfection methods.
For electroporation, ;90% conﬂuent cells in a ﬂask were washed once
with 13 phosphate buffered saline (PBS), trypsinized with 0.25% trypsin-
0.03% EDTA solution for 5 min at 37C, and then resuspended in culture
medium. Cells (;1 3 106) were precipitated by centrifugation and
resuspended in culture medium in an electroporation cuvette, 2-mm wide.
After mixing the cells with DNA, 10 mg in total, the cuvette was chilled on
ice for 10 min. GenePulser Xcell (Bio-Rad) was used for electroporation
by following the manufacturer’s preprogrammed protocol for CHO cells.
After electroporation, cells were left for 10 min at room temperature, and
;50,000 cells/well were seeded in wells of a six-well plate containing
FIGURE 1 (A) Schematic overview of FP-
fusion constructs. PMT-FPs, (from left to right)
PMT-CFP, PMT-GFP, PMT-YFP, and PMT-
mRFP. EGFR-FPs and ErbB2-FPs are listed in
the same order. ECD, extracellular domain;
TMD, transmembrane domain; ICD, intracellular
domain; K, kinase domain. (B) Example images
of cells expressing different constructs. mRFP-
EGFR-GFP, positive control for SW-FCCS.
(Left) Image in GFP channel, (middle) image in
mRFP channel, and (right) overlapping image.
Note that mRFP and GFP images do not com-
pletely overlap each other possibly due to the
cleavage of FP through the receptor’s recycling.
Bar, 10 mm.
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prewashed coverglasses (30 mm in diameter; Lakeside, Monee, IL). For
Fugene 6 transfection, cells were seeded in six-well plates containing the
30-mm coverglasses at 1 3 105 cells/well one day before transfec-
tion. CHO cells were transfected with plasmids by following the standard
Fugene 6 protocol (Roche). Two days after transfection, cells were washed
once with 13 PBS, and were further cultivated in F12K medium con-
taining 0.1% FBS, 50 U/ml penicillin G, and 50 mg/ml streptomycin for
8–16 h.
At the time of observation, cells were treated under different conditions
according to different experimental targets. To observe effective internal-
ization of the fusion receptors, cells were washed several times with 13 PBS
and covered with D-MEM/F-12K medium lacking of phenol red in a POC
minichamber (Carl Zeiss, Jena, Germany), and confocal imaging of the
fusion receptor internalization was done at 37 by using a heating stage and a
temperature regulator ‘‘Tempcontrol 37-2 digital’’ (Carl Zeiss). To keep a
lowﬂuorescence background during FRETmeasurements, cells werewashed
once with 13 PBS and covered with Hanks’ balanced salt solution lacking
phenol red in the minichamber for FRET measurements. For FCCS
measurements, cells were washed thoroughly with 13 PBS and covered
with 1ml 13 PBS in theminichamber duringmeasurements. EGFwas added
in two experiments, confocal imaging of the fusion receptor internalization
andSW-FCCSobservation on the fusion receptors after EGF stimulation. The
ﬁnal concentration of EGF was kept at 100 ng/ml for both internalization
imaging and SW-FCCS observation. Because SW-FCCS mainly focused on
cell membrane, to avoid fast internalization of the membrane receptors after
EGF activation during SW-FCCS observation, cells were incubated with
endocytosis inhibitors one-half hour before adding EGF. The ﬁnal concen-
tration of the inhibitors was NaN3 (Sigma, St. Louis, MO), 10 mM; NaF
(Sigma), 2 mM; 2-deoxy-D-glucose (Sigma), 5 mM, respectively.
Fig. 1 B shows some example images of cells expressing FP-fusion
constructs. Fluorescence was clearly shown on cell membrane, which sug-
gests that FP-fusion does not affect the translocation of the receptors. Cell
images were taken on a Zeiss laser scanning confocal microscope LSM510
META (Carl Zeiss). The imaging of FP-fusion EGFR internalization after
ligand stimulation was also carried out on a laser scanning confocal micros-
cope LSM510 (Carl Zeiss).
Phosphorylation assay of receptor chimera
with FP
To analyze autophosphorylation activity of the chimeric EGFR constructs,
the expression plasmid vector DNAs, 2–8 mg each, were introduced into
COS-7 cells (ATCC), ;1 3 106 cells per tube, by using a Nucleofector II
(amaxa GmbH, Germany) under preset conditions by the manufacturer.
After cultivating the transfected cells for two days in a culture dish (6 cm in
diameter), cells (;3 3 106) were starved in the absence of serum for 24 h,
and were then stimulated with 100 ng/ml (a ﬁnal concentration) of EGF on
ice for 30 min (24). After washing three times with ice-cold 13 PBS, the
cells were solubilized with 13 Laemmli sample buffer (100 ml; Bio-Rad)
supplemented with 1.0 mM Na3VO4 and 5% mercaptoethanol, and were
heat denatured for 10 min at 95C. Samples were stored at 86C until use.
An aliquot, 2–40 ml each per lane, of the samples was electrophoretically
separated with a 7% SDS-polyacrylamide gel, and blotted onto a Hybond-P
PVDF membrane (pore size, 0.45 mm; GE Healthcare, Little Chalfont, UK).
After blocking the membrane with 5% skimmed milk in TBS buffer (20 mM
Tris-Cl, pH 7.4, 150 mM NaCl, 0.1% Tween-20), EGFR chimera and its
phosphorylated form were stained with anti-EGFR antibody (Ab-12; Lab
Vision, Fremont, CA), and followed by incubating with a secondary anti-
body, sheep anti-mouse IgG conjugated with horseradish peroxidase. For
the detection of a phosphorylated form of the receptors, alternatively, the
membrane was blocked with a mixture of Blocking One-P (Nakalai Tesque,
Kyoto, Japan), 2% ECL Blocking reagent (GE Healthcare), and 50 mMNaF,
and was subjected for binding with anti-pTyr (PY20) antibody (sc-508;
Santa Cruz Biotech., Santa Cruz, CA) as a primary antibody and then with a
secondary antibody as described above. The proteins were visualized by
treating the membrane with an ECL Western blotting detection kit (GE
Healthcare), and were analyzed by using a Fujiﬁlm Luminescent Image
Analyzer (LAS-3000; Tokyo, Japan).
SW-FCCS setup
SW-FCCS was carried out on a modiﬁed Zeiss Axiovert 200 inverted
microscope as described elsewhere (13). For SW-FCCS measurements of
FP-fused EGFR and ErbB2, an excitation wavelength of 514 nm (argon ion
laser; Spectra-Physics, Mountain View, CA) at 40–70 mW was used. The
excitation light was reﬂected by a dichroic mirror, 525DRLP (Omega Op-
tical, Brattleboro, VT), and focused by a water-immersion objective (633,
NA 1.2; Carl Zeiss) into samples. Fluorescence light was spatially ﬁltered
through a 50-mm pinhole (Linos, Heidelberg, Germany) and was split by a
second dichroic mirror, 560DCLP (Omega), into two detection channels,
green and red. Two band-pass ﬁlters, 545AF35 and 615DF45 (Omega),
were placed in front of the avalanche photodiode detectors (SPCM-AQR-14,
Pacer Components, Berkshire, UK), to further restrict the emission wave-
lengths for the green and red channels, respectively. Measurements were
taken over 30 s for all experiments. Autocorrelations and cross correlations
were simultaneously calculated by using a hardware correlator (Flex-02-
12D; correlator.com, Zhejiang, China), and ﬁtting of the correlation func-
tions was carried out with Igor Pro 4.0 (Wavemetrics, Portland, OR). As
mentioned before, SW-FCCS measurements on transfected cells were done
in a POC minichamber containing 13 PBS (1 ml) after washing the cells
thoroughly with 13 PBS. All the measurements were done at room tem-
perature. Data are presented as the mean 6 SD, or mean 6 SE, and differ-
ences between groups were compared using Student’s t-test (one-tailed).
SW-FCCS calculation on the fractions of dimers
In ﬂuorescence correlation methods the count rate per particle and second
(cps) is an important factor determining the amplitude of the correlation
function. Thus these values have to be known for each ﬂuorophore and
channel. We have adopted the following naming convention:
hGg , cps of EGFR-GFP in the green channel.
hGr , cps of EGFR-GFP in the red channel.
hRg , cps of EGFR-mRFP, or mRFP-EGFR in the green channel.
hRr , cps of EGFR-mRFP, or mRFP-EGFR in the red channel.
bg, background count rate in the green channel on a cell membrane.
br , background count rate in the red channel on a cell membrane.
For the calculation of dimer percentages we assume that the count rate of
doubly labeled molecules is just the sum of the count rates of the singly
labeled molecules because in general there was no FRET observed between
GFP and mRFP in our system:
h
2G
g ¼ 2hGg ; (1)
h
2G
r ¼ 2hGr ; (2)
h
2R
g ¼ 2hRg ; (3)
h
2R
r ¼ 2hRr ; (4)
h
GR
g ¼ hGg 1hRg ; (5)
and
h
GR
r ¼ hGr 1hRr : (6)
Cross- and autocorrelation functions for this case are given by:
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where concentrations are denoted by a c (13,14). The superscript G and R
refer to EGFR-GFP and EGFR-mRFP monomers, respectively. The super-
script 2G or 2R refers to EGFR-GFP/-GFP or EGFR-mRFP/-mRFP dimers,
whereas GR refers to mixed dimers of EGFR-GFP/-mRFP. NA is Avogadro’s
number and Veff is the effective observation volume. It should be noted that
the actual values of NAVeff has no inﬂuence on our results since only relative
molecular fractions are determined but no absolute concentrations.
We assume that dimerization does not depend on FPs attached to the
receptor, and this is supported by the fact that amino- and carboxyl-fusion
constructs show similar dimerization (see Table 1). Therefore, the formation
of dimers containing GFP/GFP, mRFP/mRFP, mRFP/GFP, and GFP/mRFP
is equally likely and their occurrence depends only on the absolute amounts
of GFP- and mRFP-labeled molecules present. For instance, the formation of
an EGFR-GFP/-mRFP dimer depends on the probability of ﬁnding an EGFR
dimer, pD, times the probability of ﬁnding an EGFR-GFP, pG, times the
probability of ﬁnding an EGFR-mRFP, pR. The probability pD of dimer
formation depends on the afﬁnity of the EGFR for itself. The probability pG
is determined by the total number of EGFR-GFP divided by the total
concentration of EGFR molecules. Similarly the probability pR is deter-
mined by the total number of EGFR-mRFP divided by the total concen-
tration of EGFR molecules, ctot:
ctot ¼ cG1 cR1 2ðc2R1 c2G1 cGRÞ (10)
pG ¼ c
G1 2c2G1 cGR
ctot
(11)
pR ¼ c
R1 2c2R1 cGR
ctot
(12)
c
2G ¼ pD p2Gctot (13)
c
2R ¼ pD p2Rctot (14)
c
GR ¼ 2 pD pGpRctot (15)
c
2G
c
GR ¼
pG
2 pR
¼ c
G1 2c2G1 cGR
2ðcR1 2c2R1 cGRÞ; (16)
and
c
2R
cGR
¼ pR
2 pG
¼ c
R1 2c2R1 cGR
2ðcG1 2c2G1 cGRÞ: (17)
Equations 7–9, 16, and 17 are solved numerically for cG; cR; c2G; c2R, and
cGR. The percentage of dimerization is then calculated by
f ¼ 2ðc
2G1 c2R1 cGRÞ
ctot
: (18)
To extract values for Eqs. 7–9, all experimental data have been ﬁtted to a
two-dimensional model for membrane diffusion:
GðtÞ ¼ 1
N
11
4Dt
v
2
 1
Te
t=tT
1 T 1 1
 !
1GN: (19)
N is the average number of particles in the confocal volume. D is the
diffusion coefﬁcient of the receptors in the membrane, and v is the radial
distances of the confocal volume at which the intensity has dropped by 1/e2
Gxð0Þ ¼
h
G
gh
G
r c
G1hRgh
R
r c
R1h2Gg h
2G
r c
2G1h2Rg h
2R
r c
2R1hGRg h
GR
r c
GR
NAVeff h
G
g c
G1hRg c
R1h2Gg c
2G1h2Rg c
2R1hGRg c
GR1bg=ðNAVeffÞ
 
3 hGr c
G1hRr c
R1h2Gr c
2G1h2Rr c
2R1hGRr c
GR1br=ðNAVeffÞ
 1
; (7)
Ggð0Þ ¼
h
G
g
 2
c
G1 hRg
 2
c
R1 h2Gg
 2
c
2G1 h2Rg
 2
c
2R1 hGRg
 2
c
GR
NAVeff h
G
g c
G1hRg c
R1h2Gg c
2G1h2Rg c
2R1hGRg c
GR1bg=ðNAVeffÞ
 2; (8)
and
Grð0Þ ¼ h
G
r
 2
c
G1 hRr
 2
c
R1 h2Gr
 2
c
2G1 h2Rr
 2
c
2R1 hGRr
 2
c
GR
NAVeff h
G
r c
G1hRr c
R1h2Gr c
2G1h2Rr c
2R1hGRr c
GR1br=ðNAVeffÞ
 2; (9)
TABLE 1 Homo- and heterodimer fractions of EGFR and ErbB2 (including third unlabeled receptor competition) on the cell surface
Construct Dimer % (6 SD) Dimer % (6 SE) Normalized dimer % (6 SE) Sample size (n)
Cytosolic GFP/mRFP (negative) 17 6 9 17 6 2 23 6 3 20
PMT-GFP/PMT-mRFP (negative) 19 6 9 19 6 2 26 6 3 24
EGFR-GFP/EGFR–mRFP 50 6 25 50 6 6 68 6 8 18
EGFR-GFP/mRFP-EGFR 50 6 25 50 6 5 68 6 7 21
EGFR-GFP/EGFR-mRFP/wt EGFR (1:1:0.5)* 44 6 19 44 6 5 60 6 7 17
EGFR-GFP/EGFR-mRFP/wt EGFR (1:1:1)* 40 6 18 40 6 4 55 6 5 22
ErbB2-GFP/ErbB2-mRFP 50 6 26 50 6 5 68 6 7 24
ErbB2-GFP/EGFR-mRFP 62 6 21 62 6 4 85 6 5 14
mRFP-EGFR-GFP (positive) 73 6 15 73 6 4 100 6 6 14
*The ratio (1:1:0.5) was the ratio of amounts (mass) of plasmids used for transfection. So was the ratio of 1:1:1.
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of the maximum intensity. GN is the convergence value of the autocorre-
lation function for long times, and in general this value is 1. T is the average
fraction of particles that reside in the triplet state and tT is its relaxation time.
In some cases it was necessary to include two different triplet states to
account for the photodynamics of FPs.
FRET setup
Confocal laser scanning microscopy was performed on an LSM 510 META
microscope (Carl Zeiss) with an oil immersion objective lens (633, NA 1.4;
Carl Zeiss). For sensitized ﬂuorescence emission measurements, CFP and
YFP were excited sequentially through an HFT 458/514 beam splitter by
using 458 nm (30% laser intensity) and 514 nm (5% intensity) argon laser
lines, respectively. Emission ﬁlters for the CFP channel (461–504 nm) and
YFP channel (526–568 nm) were used, and FRET was detected through the
FRET channel, in which ﬂuorescence emission was monitored through the
YFP channel upon excitation at 458 nm (donor excitation). As previously
described (17,35), FRETC was calculated on a pixel-by-pixel basis for the
entire ‘‘region of interest (ROI)’’ image by the equation: FRETC ¼ FRET 
(0.40 3 CFP)  (0.15 3 YFP), where FRET, CFP, and YFP correspond to
background-subtracted ﬂuorescence intensities acquired through the FRET,
CFP, and YFP channels, respectively. The 0.4 and 0.15 are the fractions of
bleed-through of CFP and YFP ﬂuorescence to the FRET channel, respec-
tively. The fractions were calculated by measuring ﬂuorescence intensities
of cells individually expressing EGFR-CFP or EGFR-YFP through the CFP,
YFP, and FRET channels. FRETC was also normalized for both CFP and
YFP intensities (FRETC / (C3 Y)1/2). All the experiments were done at room
temperature (;22C).
FRET spectra were obtained by scanning images from 462 to 612 nm in
the META mode after exciting cells at 458 nm (30% laser intensity). After
subtracting background ﬂuorescence, ﬂuorescence intensities were plotted
against emission wavelengths, and were further normalized for intensities at
495 nm. Data are presented as the mean 6SD, and differences between
groups were compared using Student’s t-test (one-tailed).
RESULTS AND DISCUSSION
Calibration
A precondition for SW-FCCS is that ﬂuorophores have to
have similar excitation spectra but well-separated emission
spectra (7,14). Due to the broad emission spectra of the FPs,
cross talk in this system is unavoidable. In addition, cells
possess an autoﬂuorescence background that contributes
differently to the two different channels. We thus ﬁrst char-
acterized every component according to their ﬂuorescence
characteristics. A laser power of 40 mW before the objective
was chosen since at this level no obvious photobleaching
could be observed in the ﬂuorescence intensity traces or
autocorrelation functions (ACFs). The following values are
averages using an excitation wavelength of 514 nm and a
laser power of 40 mW in our microscope settings:
h
G
g ¼ 2000
h
G
r ¼ 200
h
R
g ¼ 0
h
R
r ¼ 2000
bg ¼ 1800
br ¼ 2800:
The position of FP, i.e., whether attached to the amino- or
carboxyl-terminus, did have minimal inﬂuence on the count
rate. However, cytosolic GFP (2400 cps) and mRFP (1500
cps) had somewhat different cps, and that of PMT-GFP and
PMT-mRFP ranged between ;1100 and 2000 cps, and 800
and 2000 cps, respectively.
Phosphorylation and internalization of receptor
chimera with FP
It has been reported that activities of the chimeric receptor
proteins are indistinguishable from the native proteins in
terms of cell surface expression, and EGF-induced phos-
phorylation and internalization (30,36). Similar results are
obtained here. When all the constructs were introduced into
CHO cells, the chimeric proteins were expressed on the cell
surface as shown in Fig. 1 B. When the EGFR constructs
were introduced singly into COS-7 cells, which give higher
protein expression levels compared to CHO cells, the chi-
meric receptor proteins were phosphorylated upon EGF bind-
ing (Fig. 2 A). When the cells were incubated with EGF (100
ng/ml), the chimeric EGFRs on the cell surface were efﬁ-
ciently internalized within 30 min or less except for chimeras
with the amino-terminal fusion, mRFP-EGFR and mRFP-
EGFR-GFP, whose internalization was slower than other
EGFR constructs with carboxyl-terminal fusion and took up
to 50 min for complete internalization (Fig. 2 B). This sug-
gests that FP fusion with EGFR at its amino-terminus may
affect the binding efﬁciency of the receptor for EGF. None-
theless, the chimeric receptor mRFP-EGFR could form di-
mers with EGFR-GFP as efﬁciently as other combinations of
chimeric receptors as shown in Table 1 and Fig. 3 D.
Determination of receptor dimer fractions on the
cell surface by SW-FCCS
To investigate if the cell-surface EGFR and ErbB2 have
preformed homo- and heterodimeric structures, we set out to
analyze the homo- and heterodimerization of EGFR and
ErbB2 by SW-FCCS. CHO cells were transfected with plas-
mid constructs encoding EGFR or ErbB2 molecules fused to
GFP or mRFP. FPs on the upper cell membrane of CHO cells
were excited by a single laser line at 514 nm, and emissions
were split by a dichroic mirror and were detected through
two band-pass ﬁlters, one for GFP and the other for mRFP.
Autocorrelation and cross-correlation curves of FPs fused to
EGFR or ErbB2 expressed on the CHO cell surface were
compared with those of FP fused to the PMT peptide as a
negative control, in which FPs were attached to the PMT se-
quence (33) so that the FP chimeras are likely to be randomly
distributed as monomers on the cytoplasmic membrane.
All of the FP-fused EGFR or ErbB2 molecules laterally dif-
fused with a similar diffusion coefﬁcient, 0.386 0.13 mm2/s
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(n ¼ 44). The amplitudes of cross-correlation curves mea-
sured from cells coexpressing EGFR-GFP/mRFP-EGFR,
ErbB2-GFP/EGFR-mRFP, or ErbB2-GFP/-mRFP were much
higher than those expected for pure cross talk (Fig. 3, D–G),
and in fact approaching the amplitude of cells expressing
the positive control mRFP-EGFR-GFP (Fig. 3 C). The am-
plitude of cross-correlation curves of the negative controls,
cells coexpressing cytosolic GFP/mRFP (Fig. 3 A) or PMT-
GFP/-mRFP (Fig. 3 B), was similar to that due to cross talk.
In all cases, cells were chosen that expressed the GFP and
mRFP constructs in similar amounts to maximize the con-
tribution to the cross correlation.
From the cross-correlation curves, the percentage of the
receptor molecules found in homo- or heterodimers were
calculated and summarized in Table 1. We never observed
100% cross correlation even for the positive control. One
important reason may be that not all mRFP molecules func-
tion as ﬂuorescent molecules, as reported by Hilleshein et al.
(37). There also may be some other reasons, such as instabil-
ity of the FPs against photobleaching and/or enzymatic
degradation. With the average value of 73% dimerization
measured in the positive control, SW-FCCS suffers from a
problem similar to the zero-efﬁciency peak observed in
FRET (38), which is caused by the absence of the acceptor
on a subpopulation of molecules. However, in the case of
SW-FCCS this problem is more severe since both the ab-
sence of a GFP as well as the absence of an mRFP molecule
would lead to a reduced value of dimer formation. When
comparing the standard deviation of the positive control and
the other experiments it is evident that the positive control
shows a much smaller standard deviation. This can be
explained by the fact that in this case only FP stability
FIGURE 2 (A) Phosphorylation assay of FP-
fused EGFR constructs. The chimeric con-
structs were introduced into COS-7 cells, and
the cell lysates were prepared before () and
after (1) stimulation with EGF. The lysates
were blotted on ﬁlter membranes, and stained
with anti-EGFR antibody (a-EGFR) or anti-
phosphotyrosine antibody (a-pTyr). Note that
COS-7 cells express the wild-type EGFR detec-
table by staining with the antibodies, particularly
in the lanes of EGFR-GFP and untransfected
COS-7. As a reference, a cell lysate of A431,
which overexpresses the wild-type EGFR, was
also included in the lane furthest to the right.
Arrowheads indicate the positions of a molec-
ular marker, 204-kDa myosin heavy chain. (B)
FP-fusion EGFR internalization after EGF stim-
ulation. (Left) Images before adding EGF; (middle)
images show a certain scale of internalization
after certain time of EGF stimulation; (right)
images show large scale of internalization after
longer time of EGF stimulation.
690 Liu et al.
Biophysical Journal 93(2) 684–698
determines the fraction of double-labeled complexes ob-
served and there is no inﬂuence of any other biological fac-
tors on actual complexation between the two ﬂuorophores.
This upper limit of observable dimerization, caused by arti-
facts of the FP stability, leads to an underestimation of the
actual dimer fraction and these values therefore constitute
a lower limit of dimerization. We give in Table 1 also the
dimer fractions normalized to the average value of 73%
observed in the positive control to show the upper limit of
dimerization. The dimer percentages observed for the homo-
and heterodimers were signiﬁcantly higher (P # 0.001) than
that for the negative control. All the three dimer percentages
were similar to one another, and might not be signiﬁcantly
different (P . 0.05), indicating that the majority of the
receptor molecules have dimeric structures on the cell sur-
face. These dimer percentages were not affected by the
FIGURE 3 Auto- and cross-correla-
tion curves measured from CHO cells
expressing chimeric FPs. Autocorrela-
tion curves (dashed curves) of GFP
(green) and mRFP (red), and cross-
correlation curves (blue) between the
two are shown with their ﬁts (solid
curves). Black dotted lines represent
cross-correlation levels due to cross talk
between the two channels. (A) Cell
coexpressing cytosolic free GFP and
mRFP (negative control 1). (B) PMT-
GFP/-mRFP (negative control 2). No
cross correlation, hence no interaction,
between the two FPs was observed. (C)
Cell expressing mRFP-EGFR-GFP
(positive control), in which mRFP and
GFP were fused in tandem to N- and
C-termini of EGFR, respectively. (D)
Cell coexpressing EGFR-GFP/mRFP-
EGFR. Similar auto- and cross-correlation
curves were also observed for cells co-
expressing EGFR-GFP/-mRFP (E). (F)
Cell coexpressing ErbB2-GFP/EGFR-
mRFP. (G) Cell coexpressing ErbB2-
GFP/-mRFP.
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receptor expression levels ranging from 2.0 3 104 to 2.6 3
105 molecules per cell (Fig. 4). This indicates that the re-
ceptor homo- and heterodimerization are not dependent on
receptor expression levels, as previously observed for EGFR
homodimerization (24).
To further conﬁrm the dimer faction of the receptors
obtained from SW-FCCS, a third unlabeled receptor was in-
troduced to the coexpression system of FP-fusion receptors
(i.e., EGFR-GFP/EGFR-mRFP) by adding a third wt EGFR
plasmid (pNUT/EGFR) in transfection. The third wt EGFR
would compete with the dimer formation between EGFR-GFP
and EGFR-mRFP, thus a decrease of dimer fraction should
be observed. This is shown in Table 1 with two sets of triple-
transfection data. The dimer faction of EGFR-GFP/EGFR-
mRFP decreases with the increase of the amount of the third
plasmid. With the increase of the ratio of EGFR-GFP/EGFR-
mRFP/wt EGFR from 1:1:0.5 to 1:1:1, the dimer faction
drops from 44% to 40%, and both are lower than that of the
coexpression of EGFR-GFP/EGFR-mRFP (50%). Note that
the ratio was the mass ratio of different plasmids and the
molar ratio may be different (which depends on the vector
size). Besides, each individual cell may take in different
amounts of the plasmids. As the third unlabeled receptor is
not detectable in SW-FCCS and the concentration of wt
EGFRmay differ from cell to cell, the competition effect may
differ from that estimated by the plasmid ratio. However, the
averaged values of the dimer fraction from different sets of
cell samples can still indicate the competition effect, which
conﬁrms that SW-FCCS is applicable to study protein-
protein interactions in live cells.
The dimer fractions of the receptors obtained from SW-
FCCS, which were done at room temperature (RT), are
comparable with the chemical cross-linking results reported
by Moriki et al., which were done at 37C (24). Thus we
assume that there is little inﬂuence on dimer formation
between 37C and RT. Similar to the report by Bacia et al.
where they discussed the advantages of FCS done at RT (39),
here we performed SW-FCCS at RT considering the photo-
stability of FPs and slower endocytosis rate of membrane
receptors at RT than at higher temperature.
SW-FCCS on cells after EGF stimulation
After EGF stimulation the ACF and cross-correlation func-
tion (CCF) curves on the membrane undergo dramatic
changes. When focusing on a single position on a cell di-
rectly after stimulation the process during receptor activation
can be detected. Fig. 5 shows the observation of clustering of
EGFR-GFP and EGFR-mRFP by SW-FCCS. In the ﬁrst
minutes changes are small and the ACF and CCF curves are
similar to the state before EGF stimulation (Fig. 5, A and B).
After a longer time of ;10 min after stimulation, irregular
high intensity ﬂuorescence peaks are detected, consistent
with receptor clustering on the membrane (Fig. 5, C and D).
The observation of EGFR receptor clusters on membrane
after activation is consistent with the report by Lakadamyali
et al. (40), which implies that SW-FCCS may be applied to
monitor receptor activation in vivo.
Stability of the mathematical determination of
the dimer fraction
From the different count rates detected for cytosolic and
membrane-targeted FPs, it is clear that under the experi-
mental conditions used, the cps of the FPs can range between
;1000 and 2000 counts. In particular, the cps depends on
how well the focal volume is focused on the membrane (41).
These variations could affect the calculation of the dimer
fractions. Thus we calculated the dimer fractions assuming
the lower range of cps of hGg ¼ 1100, hGr ¼ 100, hRg ¼ 0,
and hRr ¼ 800 but assuming the same background count
rates as above. However, the dimer fraction determined did
not change signiﬁcantly in any of the cases. The fraction of
dimers determined depends on individual values for the ﬂuo-
rescence yield and background. However, when all the
values were changed by the same factor, as would happen in
a limited range when changing the laser intensity or de-
focusing from the membrane, the dimer fraction determined
FIGURE 4 Dimerization percentages versus receptor expression level. (A)
Coexpression of EGFR-GFP/EGFR-mRFP, and coexpression of EGFR-
GFP/mRFP-EGFR. (B) Coexpression of ErbB2-GFP/ErbB2-mRFP. (C)
Coexpression of EGFR-GFP/ErbB2-mRFP. (D) Positive control mRFP-
EGFR-GFP, and negative control coexpression of PMT-GFP/PMT-mRFP.
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was almost unchanged. Thus, although focusing on the mem-
brane and laser intensity changes can be problems in FCS
and FCCS (41), the inﬂuence of these effects on the dimer
fraction is small. A simultaneous change of all ﬂuorescence
yields and background values by a factor of 2 up or down did
change the dimer fractions determined by ,2 percentage
points, far smaller than the standard deviation. The exception
was the PMT-GFP/-mRFP negative control, which gave
larger values as discussed in the next section. Thus the
determination of the homo- and heterodimer fraction is stable
and does not vary strongly with changes in cps.
Negative controls and errors
The lower limit of dimer formation in the negative controls is
probably due to the fact that the background values used in
our calculations are average values over many cells. How-
ever, every cell will exhibit a different background value that
cannot be assessed independently from the expressed FPs.
Thus there is an uncertainty in the values for the background
(b) and the ﬂuorescence yield (h), which limits the accuracy
of the measurement and explains as well the large errors in
the dimer fraction. In addition, it should be noted that for the
PMT-GFP/-mRFP measurements the correlation times for
the cross correlations do not agree with those of the auto-
correlations in many cases and often the cross correlations
could not be ﬁt at all. This is very different from all the other
measurements where the correlation times of cross correla-
tions and autocorrelations do agree. This clearly indicates
that there is limited cross correlation seen in the case of the
negative controls PMT-GFP/-mRFP and free GFP/mRFP
expressed in the cytoplasm.
To conﬁrm the measurements presented above, we depict
the typical intensity traces for the positive and negative con-
trols as well as for the EGFR-GFP/mRFP-EGFR coexpres-
sion (Fig. 6). Although in the positive control the signal in
the two different detection channels is strongly correlated, in
the negative control this is not the case. In the case of EGFR-
GFP/mRFP-EGFR coexpression the intensity traces show
correlations, but there are as well intensity peaks appearing
FIGURE 5 Auto- and cross-correla-
tion curves measured from one CHO
cell expressing EGFR-GFP/EGFR-
mRFP before and after ligand stimula-
tion. (A) ACF and CCF curves before
adding EGF. (B, C, and D) 4 min, 11
min, and 13 min after EGF stimulation,
respectively.
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only in either the red or the green channel. These uncorre-
lated peaks could be due to either EGFR-GFP/-GFP and
mRFP-EGFR/-EGFR dimers or to monomeric forms of these
proteins.
Inﬂuence of FRET between GFP and mRFP on the
calculated dimer fraction
As reported in the next section we detected FRET between
EGFR-CFP and -YFP coexpressed in CHO cells. GFP and
mRFP are reported to have a similar Fo¨rster distance as CFP/
YFP of ;4.7 nm (42), and thus it is important to determine
whether there is any FRET between EGFR-GFP and -mRFP.
This would inﬂuence the ﬂuorescence yield values h and
thus the calculated dimer fractions. To test whether there is
any FRET and if it has any inﬂuence on our results, we
coexpressed EGFR-GFP with either EGFR-mRFP or mRFP-
EGFR, where mRFP is attached to either the -carboxyl or the
amino-terminus. Coexpression of the constructs leads then to
a situation where GFP and mRFP are either both on the
cytoplasmic side (Fig. 3 E) and are possibly in close contact
(similar to the EGFR-CFP/-YFP situation), or where GFP is
on the cytoplasmic side and mRFP on the extracellular side
of the membrane (Fig. 3 D), at a larger distance from each
other.
As can be seen from Fig. 3, D and E, and Table 1, the
measured cross correlation and calculated fraction of dimers
is the same for both situations. We thus conclude that there is
either no FRET or no signiﬁcant inﬂuence of FRET on our
measurements. This is probably due to the fact that mRFP
has a long excitation tail on the short wavelength side, which
allows direct excitation of mRFP by the 514 nm line of the
laser and makes it a bad FRET acceptor (15). Furthermore,
the excitation of GFP at 514 nm is reduced so that the direct
excitation of mRFP largely dominates compared to FRET
from GFP to mRFP. This is in agreement with the work of
Saito et al., who have not found any FRET in a GFP/mRFP
pair linked by the D4K linker (1).
Incidentally, this experiment demonstrates as well that a
dimerization due to the interaction between FPs can be ex-
cluded since for the EGFR-GFP/mRFP-EGFR the FPs reside
on different sides of the membrane.
FRET-based observation of receptor dimers on
the surface of live cells
To further conﬁrm the preformed dimeric structures of the
receptors, we also tried to detect FRET between FPs fused to
the receptor molecules. CHO cells were cotransfected with
the FP-fused receptor constructs by electroporation, and cells
expressing ;5 3 104 molecules per cell, with the ratios of
YFP/CFP ranging from one to three, were selected based on
their ﬂuorescence intensities (Fig. 7). CHO cells have an
advantage of no endogenous expression of EGFR family
members except for a low background expression of ErbB2,
considering that very few cell lines express EGFR in the
absence of ErbB2 (43,44). The ﬂuorescence intensities
of CFP-, YFP-tagged chimeric receptors were measured
through three ﬁlter sets (CFP, YFP, and FRET channels);
corrected FRET values (FRETC) were calculated according
to a previously published method (17,36), whereby ﬂuores-
cence intensity measured through the FRET channel was
corrected for cross talk between the channels. Examples of
such FRETC are shown in Table 2. All the FRETC intensities
between EGFR-CFP and -YFP, ErbB2-CFP and -YFP, and
ErbB2-CFP and EGFR-YFP were statistically signiﬁcantly
higher (P , 0.001) than that of the negative control PMT-
CFP/-YFP, whereas they were lower than that of the positive
control PMT-CFP-YFP, in which FPs were tandemly fused
to PMT. These results summarized in Table 2, in which
FRETC intensities were normalized for intensities of CFP
and YFP as described previously (45), suggest that EGFR
and ErbB2 are able to preform homo- and heterodimers
without bound ligand on the cell surface at physiological
expression levels.
To verify the FRET results above, we also tried to detect a
ﬂuorescence intensity increase of YFP due to FRET as
previously shown (45,46). CHO cells were cotransfected
FIGURE 6 Intensity traces of positive and negative controls, and EGFR-
GFP/mRFP-EGFR. The long wavelength channel (mRFP) is depicted in red,
and the short wavelength channel (GFP) in green. (A) The positive control
shows that peaks in the red and green channels appear mainly simulta-
neously as expected. (B) For the EGFR-GFP/mRFP-EGFR coexpression,
some peaks are correlated (shaded area 1), some are most likely due to cross
talk (shaded area 2), and some are uncorrelated (shaded area 3). (C) In the
negative control the signals in the two channels are uncorrelated except some
residual correlation due to cross talk.
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with chimeric constructs between the receptor, EGFR or
ErbB2, and FP, CFP, or YFP. Cells transiently expressing
the chimeric proteins on the cell surface at physiological
levels were selected based on ﬂuorescence intensities, and
emission wavelength scans were performed in the range of
462–612 nm with the excitation wavelength of 458 nm. If
CFP and YFP were in close proximity due to homo- or
heterodimerization of the receptors, higher peaks at 537 nm
(YFP emission due to FRET) should be observed after
normalization of the spectra to ﬂuorescence intensities at an
emission wavelength of 494 nm (CFP emission) than that
of the negative control. As shown in Fig. 8, A–C, indeed,
spectral peaks at 537 nm of cells coexpressing EGFR-CFP/-
YFP, ErbB2-CFP/-YFP, and ErbB2-CFP/EGFR-YFP were
statistically signiﬁcantly higher (P , 0.001) than that of the
negative control PMT-CFP/-YFP, but lower than that of the
positive control PMT-CFP-YFP. A similar spectrum to that
of ErbB2-CFP/EGFR-YFP was also obtained for cells coex-
pressing EGFR-CFP/ErbB2-YFP (Fig. 8 D).
Comparison between FRET and SW-FCCS data
FRET data was used in this work to conﬁrm the interaction
between the protein constructs and thus as a support for the
SW-FCCS data. Although FRET data indicated that EGFR
and ErbB2 form homo- and heterodimers, the transfer ef-
ﬁciency found is low. This is consistent with other work on
FRET of ﬂuorescent proteins in which FRET for CFP/YFP
constructs with a distance of;52 A˚ show a FRET efﬁciency
of only 33% (47) consistent with a Fo¨rster radius of 47.5 A˚
(42). The distance between the kinase domains of EGFR
dimers is ;50 A˚ (48). Taking this as an average distance for
the C-terminal FPs we would expect a FRET efﬁciency of
42% or less as seen in our measurements. SW-FCCS mea-
surements conﬁrm the interaction and allow quantiﬁcation of
the dimer formation on the cell surface. From the measured
average values and standard deviations we suggest that the
majority of EGFR and ErbB2 receptors are found in homo-
and heterodimers before activation, whereas the exact amount
of dimerization can vary from point to point on a cell.
The aim of this work was to test whether preformed
dimers exist on the cell surface before EGF stimulation. We
thus used a mathematical model allowing only for the pres-
ence of monomers and dimers with the result that preformed
dimers are a prevalent form on the cell surface consistent
with models suggested in literature (24,28,30). However, we
cannot categorically exclude the presence of larger pre-
formed oligomers on the cell surface although we did not
observe intensity peaks consistent with larger oligomers or
aggregates before stimulation (Fig. 6). If they exist, their
presence would change the relative fractions of monomers
and oligomers as determined in this work. Experiments after
EGF stimulation, in contrast, show larger aggregates ap-
pearing on the cell surface, and show internalization and
phosphorylation of the proteins similar to wild-type EGFR
consistent with the detection of higher order oligomers after
activation reported in literature (30).
CONCLUSIONS
In this work we developed a novel quantitative method to
detect protein-protein interactions in vivo to assess the di-
merization properties of EGFR and ErbB2. Single wave-
length excitation ﬂuorescence cross-correlation spectroscopy
overcomes the difﬁculty of aligning two laser lines to overlap
FIGURE 7 Standard curve for the calculation of the number of receptor
molecules expressed on the cell surface from ﬂuorescence intensities.
Confocal images of CHO cells expressing EGFR fused to YFP at low,
medium, and high levels were obtained, and ﬂuorescence intensities of ROI
with a ﬁxed size were measured. The same populations of the cells were also
observed by FCS to measure the number of the receptor molecules in the
confocal volume, from which the number of the receptor molecules per cell
was calculated using 0.196 mm2 of the membrane area in the confocal
volume and 482 mm2 as the average surface area of CHO cells. For this
calculation, we assumed that particles detected by FCS consist of two
receptor molecules (dimer). The number of molecules of CFP was also
similarly estimated from its ﬂuorescence intensity based upon the ﬂuores-
cence intensity ratio, 0.22, of CFP/YFP under the experimental conditions
used. The ratio was determined by measuring ﬂuorescence intensities of
cells expressing CFP-EGFR-YFP or YFP-EGFR-CFP, in which CFP and
YFP were fused to the amino- and carboxyl termini under the same experi-
mental conditions. ‘‘No. of molecules per cell’’ and ‘‘F’’ represent the mean
number of molecules per cell and the mean ﬂuorescence intensity of ROI,
respectively. Data points are the mean 6 SD of more than six cells.
TABLE 2 FRET between FPs fused to EGFR and ErbB2 on
the cell surface
Construct
FRETC/O(C*Y)
(6 SD)
No. of molecules/cell*
(6 SD)
Sample
size (n)
PMT-CFP/-YFP
(negative)
0.036 6 0.026 66,000 6 17,000 38
EGFR-CFP/-YFP 0.103 6 0.040 56,000 6 22,000 31
ErbB2-CFP/-YFP 0.078 6 0.038 61,000 6 21,000 17
EGFR-CFP/ErbB2-YFP 0.157 6 0.077 37,000 6 14,000 18
ErbB2-CFP/EGFR-YFP 0.179 6 0.086 43,000 6 22,000 23
PMT-CFP-YFP
(positive)
0.476 6 0.083 52,000 6 23,000 35
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each other for dual-laser excitation and instead uses a single
laser line for the one-photon excitation of two ﬂuorophores
with similar excitation characteristics but separable emission
spectra. In this case GFP and mRFP were chosen as ﬂuo-
rescent labels since their photocharacteristics make them an
ideal pair for SW-FCCS at 514 nm excitation. First, the
emission spectra of GFP and mRFP are well separated and
both FPs are more photostable, compared to the CFP/YFP
pair. Second, the absorption peak around 510 nm of mRFP
(42) gives sufﬁcient red signal for excitation at 514 nm and
the excitation of GFP not at its excitation maximum results in
comparable signals in both channels with minimum cross
talk, which is conﬁrmed by quantitative analysis on positive
and negative controls.
Crystal structures of the extracellular domain of EGFR
suggest that ligand binding releases the intramolecular tether,
and makes the ‘‘dimerization’’ arm available for intermo-
lecular interaction of two extracellular domains of the recep-
tor molecules (49–51). Furthermore, crystal structures of the
extracellular domain of ErbB2 have revealed that it has an
untethered structure, and resembles the ligand-bound form of
EGFR (52,53). The receptor homo- and heterodimers on the
cell surface may be able to take two major structures, one
with an intramolecular tether, which is similar to ligand-
unbound EGFR, and the other with an untethered structure
like ErbB2. These two structures may correspond to the
receptors on the cell surface, which have low and high
afﬁnities for EGF, respectively, as discussed previously (23).
Indeed, weakening of the intramolecular tether by mutations
increases the proportion of high afﬁnity sites, and strength-
ening of the tether abolishes high afﬁnity binding (54).
Coexpression of ErbB2 with EGFR increases the fraction of
high-afﬁnity receptors without alteration of the total number
of EGF binding sites per cell (55). This suggests the inter-
molecular interaction between EGFR and ErbB2 before
ligand binding, and is consistent with the preformed het-
erodimeric structure demonstrated by this work. The unteth-
ered ‘‘dimerization’’ arm of ErbB2 may transiently interact
with that of EGFR in the heterodimeric structure, resulting in
the increase in the population of high-afﬁnity receptors.
Using SW-FCCS we have demonstrated that members of
the EGFR family receptors at physiological expression levels
have preformed homo- and heterodimeric structures on the
cell surface. These ﬁndings are supported as well by other
recent publications (30,56) and are, indeed, consistent with
the homodimeric structures of the EGFR kinase domain (57),
FIGURE 8 Preformed homo- and heterodi-
mers of EGFR and ErbB2 detected by FRET
on the live cell surface. Fluorescence spectra
(dashed line) were measured on live CHO cells
coexpressing EGFR-CFP/-YFP (A), ErbB2-
CFP/-YFP (B), ErbB2-CFP/EGFR-YFP (C),
and EGFR-CFP/ErbB2-YFP (D) by confocal
microscopy, and were normalized for ﬂuores-
cence intensities at 498 nm. Spectra of the
positive (black line) and negative (gray line)
controls, and P-values between ﬂuorescence
intensities of cells expressing the chimeric re-
ceptors and the negative control are also shown.
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transmembrane domain (58), and unactivated extracellular
domain (51) that have previously been determined. Ligand-
induced intermolecular interaction of the two ‘‘dimeriza-
tion’’ arms in the homo- and heterodimers may also induce
the rotation/twist of the transmembrane domains of the re-
ceptor dimers, and may result in dissociation of the dimeric
kinase domains for receptor activation (24). The dissociated
kinase may phosphorylate tyrosine residues in the receptor’s
regulatory domain and other substrates through allosteric
activation by asymmetric kinase domain dimers as recently
demonstrated (48). When inhibitors against the receptor kinase
are developed as anticancer drugs, the preformed homo- and
heterodimeric structures of the receptors should be consid-
ered because they may dissociate the dimeric cytoplasmic
kinase domains (24,57). These homo- and heterodimeric
structures of EGFR and ErbB2 raise the possibility of new
anticancer drugs acting at the receptor dimer interface.
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